Value Creation Consulting
A Closer Look at the Parexel Deal
Mid-Size CRO Market Update: Battle for Customers is Heating Up
Clinipace CEO, Founder Steps Aside, Hands Reins Over to New Blood
Are Biotech Companies Strong Investments?
CROs dMed and Clinipace Merge to Accelerate Customer Success
How Standardization Can Be An Innovation In Clinical Outsourcing
The Changing Landscape of the CRO Industry
Medical Device CROs: The Next Growth Opportunity?
Is A Bigger CRO Better? The Importance of Midsized CROs in Pharmaceutical and Medical Device Development
2015 CFO Awards: Finalist – Jason Monteleone, Theorem Clinical Research (Medium Companies)
Executive Leaders Radio - Jason Monteleone
Philadelphia SmartCEO Announces the 2015 Executive Management Award Winners
PE's Unclear Role in CRO Industry Leaves Sponsors 'Uncomfortable' Says Expert
"Being David in an Industry of Goliaths" to Be Presented by Theorem CFO at Philadelphia Summit
Theorem Hunts for Acquisitions After Snagging Credit Line with GE Capital
2018 DIA Meeting PharmaVoice Interview
"Being David in an Industry of Goliaths"
Demonstration on how mid-size Clinical Research Organizations (CROs) can differentiate and be successful against larger competitors. Theorem Clinical Research used as the case study.
Join our mailing list
Never miss a blog or an update!